Utah Retirement Systems’s NovoCure NVCR Stock Holding History

Utah Retirement Systems’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,900	Closed	-$743K	–	992
2023 Q2	$743K	Sell	17,900 -600	-3%	-$37.3K	0.01%	787
2023 Q1	$1.11M	Buy	18,500 +100	+0.5%	+$7.99K	0.02%	714
2022 Q4	$1.35M	Hold	18,400	–	–	0.02%	614
2022 Q3	$1.4M	Buy	18,400 +100	+0.5%	+$7.8K	0.02%	591
2022 Q2	$1.27M	Hold	18,300	–	–	0.02%	624
2022 Q1	$1.52M	Sell	18,300 -300	-2%	-$22.1K	0.02%	627
2021 Q4	$1.4M	Buy	18,600 +100	+0.5%	+$10K	0.02%	690
2021 Q3	$2.15M	Sell	18,500 -900	-5%	-$136K	0.03%	537
2021 Q2	$4.3M	Buy	19,400 +100	+0.5%	+$19.5K	0.06%	339
2021 Q1	$2.55M	Sell	19,300 -800	-4%	-$127K	0.04%	486
2020 Q4	$3.48M	Buy	20,100 +1,000	+5%	+$137K	0.05%	361
2020 Q3	$2.13M	Buy	19,100 +200	+1%	+$16K	0.04%	459
2020 Q2	$1.12M	Buy	18,900 +6,000	+47%	+$395K	0.02%	624
2020 Q1	$869K	Buy	+12,900	New	+$1.02M	0.02%	633

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Utah Retirement Systems's NVCR Position: Q3 2023 in Review

Utah Retirement Systems sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 17,900 shares — an estimated $743K sold.

Utah Retirement Systems first reported a position in NVCR in Q1 2020 and held it in 14 quarters. The position peaked at $4.3M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

Utah Retirement Systems reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
Utah Retirement Systems sold 17,900 NovoCure shares in Q3 2023, an estimated $743K.
Utah Retirement Systems first reported a position in NovoCure in Q1 2020 and held it in 14 quarters.
Utah Retirement Systems's NovoCure position peaked at $4.3M in Q2 2021.
226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Utah Retirement Systems's 13F filing for Q3 2023, filed 14 Nov 2023.